 | • レポートコード：QYR9ST02275 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の抗うつ薬市場について調査・分析し、以下の構成でお届け致します。抗うつ薬の種類別には、大鬱病性障害、強迫性障害、全般性不安障害、パニック障害、その他に、用途別には、三環系抗うつ薬、選択的セロトニン再取り込み阻害剤、セロトニン-ノルエピネフリン再取り込み阻害剤、モノアミンオキシダーゼ阻害剤、セロトニン拮抗薬及び再取り込み阻害薬、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別抗うつ薬売上データ ・地域別抗うつ薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別抗うつ薬市場規模：大鬱病性障害、強迫性障害、全般性不安障害、パニック障害、その他 ・用途別抗うつ薬市場規模：三環系抗うつ薬、選択的セロトニン再取り込み阻害剤、セロトニン-ノルエピネフリン再取り込み阻害剤、モノアミンオキシダーゼ阻害剤、セロトニン拮抗薬及び再取り込み阻害薬、その他 ・主要メーカーの企業情報：Alkermes、Allergan、Bristol Myers Squibb、Eli Lilly、GlaxoSmithKline、Lundbeck、Merck、Pfizer、Teva、Takeda ・抗うつ薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps in the treatment of depression. The global Antidepressant Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antidepressant Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Antidepressant Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antidepressant Drugs in these regions.
This research report categorizes the global Antidepressant Drugs market by top players/brands, region, type and end user. This report also studies the global Antidepressant Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Alkermes
Allergan
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Lundbeck
Merck
Pfizer
Teva
Takeda
Market size by Product
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
Market size by End User
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-norepinephrine reuptake Inhibitors
Monoamine oxidase inhibitors
Serotonin antagonist and reuptake inhibitors
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antidepressant Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antidepressant Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antidepressant Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antidepressant Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antidepressant Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antidepressant Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Antidepressant Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antidepressant Drugs Market Size Growth Rate by Product
1.4.2 Major Depressive Disorder
1.4.3 Obsessive-Compulsive Disorder
1.4.4 Generalized Anxiety Disorder
1.4.5 Panic Disorder
1.4.6 Others
1.5 Market by End User
1.5.1 Global Antidepressant Drugs Market Size Growth Rate by End User
1.5.2 Tricyclic Antidepressants
1.5.3 Selective Serotonin Reuptake Inhibitors
1.5.4 Serotonin-norepinephrine reuptake Inhibitors
1.5.5 Monoamine oxidase inhibitors
1.5.6 Serotonin antagonist and reuptake inhibitors
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antidepressant Drugs Market Size
2.1.1 Global Antidepressant Drugs Revenue 2014-2025
2.1.2 Global Antidepressant Drugs Sales 2014-2025
2.2 Antidepressant Drugs Growth Rate by Regions
2.2.1 Global Antidepressant Drugs Sales by Regions
2.2.2 Global Antidepressant Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antidepressant Drugs Sales by Manufacturers
3.1.1 Antidepressant Drugs Sales by Manufacturers
3.1.2 Antidepressant Drugs Sales Market Share by Manufacturers
3.1.3 Global Antidepressant Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Antidepressant Drugs Revenue by Manufacturers
3.2.1 Antidepressant Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Antidepressant Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Antidepressant Drugs Price by Manufacturers
3.4 Antidepressant Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antidepressant Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antidepressant Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antidepressant Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Antidepressant Drugs Sales by Product
4.2 Global Antidepressant Drugs Revenue by Product
4.3 Antidepressant Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Antidepressant Drugs Breakdown Data by End User
6 North America
6.1 North America Antidepressant Drugs by Countries
6.1.1 North America Antidepressant Drugs Sales by Countries
6.1.2 North America Antidepressant Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antidepressant Drugs by Product
6.3 North America Antidepressant Drugs by End User
7 Europe
7.1 Europe Antidepressant Drugs by Countries
7.1.1 Europe Antidepressant Drugs Sales by Countries
7.1.2 Europe Antidepressant Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antidepressant Drugs by Product
7.3 Europe Antidepressant Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Antidepressant Drugs by Countries
8.1.1 Asia Pacific Antidepressant Drugs Sales by Countries
8.1.2 Asia Pacific Antidepressant Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antidepressant Drugs by Product
8.3 Asia Pacific Antidepressant Drugs by End User
9 Central & South America
9.1 Central & South America Antidepressant Drugs by Countries
9.1.1 Central & South America Antidepressant Drugs Sales by Countries
9.1.2 Central & South America Antidepressant Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antidepressant Drugs by Product
9.3 Central & South America Antidepressant Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Antidepressant Drugs by Countries
10.1.1 Middle East and Africa Antidepressant Drugs Sales by Countries
10.1.2 Middle East and Africa Antidepressant Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antidepressant Drugs by Product
10.3 Middle East and Africa Antidepressant Drugs by End User
11 Company Profiles
11.1 Alkermes
11.1.1 Alkermes Company Details
11.1.2 Company Business Overview
11.1.3 Alkermes Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Alkermes Antidepressant Drugs Products Offered
11.1.5 Alkermes Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Company Business Overview
11.2.3 Allergan Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Allergan Antidepressant Drugs Products Offered
11.2.5 Allergan Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Company Business Overview
11.3.3 Bristol Myers Squibb Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bristol Myers Squibb Antidepressant Drugs Products Offered
11.3.5 Bristol Myers Squibb Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Company Business Overview
11.4.3 Eli Lilly Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Eli Lilly Antidepressant Drugs Products Offered
11.4.5 Eli Lilly Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Antidepressant Drugs Products Offered
11.5.5 GlaxoSmithKline Recent Development
11.6 Lundbeck
11.6.1 Lundbeck Company Details
11.6.2 Company Business Overview
11.6.3 Lundbeck Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Lundbeck Antidepressant Drugs Products Offered
11.6.5 Lundbeck Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Company Business Overview
11.7.3 Merck Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Merck Antidepressant Drugs Products Offered
11.7.5 Merck Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Company Business Overview
11.8.3 Pfizer Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Pfizer Antidepressant Drugs Products Offered
11.8.5 Pfizer Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Company Business Overview
11.9.3 Teva Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Teva Antidepressant Drugs Products Offered
11.9.5 Teva Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Company Business Overview
11.10.3 Takeda Antidepressant Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Takeda Antidepressant Drugs Products Offered
11.10.5 Takeda Recent Development
12 Future Forecast
12.1 Antidepressant Drugs Market Forecast by Regions
12.1.1 Global Antidepressant Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Antidepressant Drugs Revenue Forecast by Regions 2019-2025
12.2 Antidepressant Drugs Market Forecast by Product
12.2.1 Global Antidepressant Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Antidepressant Drugs Revenue Forecast by Product 2019-2025
12.3 Antidepressant Drugs Market Forecast by End User
12.4 North America Antidepressant Drugs Forecast
12.5 Europe Antidepressant Drugs Forecast
12.6 Asia Pacific Antidepressant Drugs Forecast
12.7 Central & South America Antidepressant Drugs Forecast
12.8 Middle East and Africa Antidepressant Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antidepressant Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Antidepressant Drugs Product Picture
Table Antidepressant Drugs Market Segments
Table Key Manufacturers Antidepressant Drugs Covered
Table Global Antidepressant Drugs Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Antidepressant Drugs Sales Market Share by Product 2014-2025
Figure Major Depressive Disorder Product Picture
Table Major Manufacturers of Major Depressive Disorder
Figure Obsessive-Compulsive Disorder Product Picture
Table Major Manufacturers of Obsessive-Compulsive Disorder
Figure Generalized Anxiety Disorder Product Picture
Table Major Manufacturers of Generalized Anxiety Disorder
Figure Panic Disorder Product Picture
Table Major Manufacturers of Panic Disorder
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Antidepressant Drugs Market Size Growth Rate by End User 2019-2025 (MT)
Figure Tricyclic Antidepressants
Figure Selective Serotonin Reuptake Inhibitors
Figure Serotonin-norepinephrine reuptake Inhibitors
Figure Monoamine oxidase inhibitors
Figure Serotonin antagonist and reuptake inhibitors
Figure Others
Figure Antidepressant Drugs Report Years Considered
Figure Global Antidepressant Drugs Market Size 2014-2025 (Million US$)
Figure Global Antidepressant Drugs Sales 2014-2025 (MT)
Table Global Antidepressant Drugs Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Antidepressant Drugs Sales by Regions 2014-2019 (MT)
Table Global Antidepressant Drugs Sales Market Share by Regions 2014-2019
Figure Global Antidepressant Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Antidepressant Drugs Sales Market Share by Regions
Table Global Antidepressant Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Antidepressant Drugs Revenue Market Share by Regions 2014-2019
Figure Global Antidepressant Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Antidepressant Drugs Revenue Market Share by Regions
Table Global Antidepressant Drugs Sales by Manufacturers (2014-2019) (MT)
Table Global Antidepressant Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Antidepressant Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antidepressant Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Antidepressant Drugs Revenue Share by Manufacturers (2014-2019)
Figure Antidepressant Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Antidepressant Drugs Price (2014-2019) (USD/Kg)
Table Antidepressant Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Antidepressant Drugs Product Type
Table Date of International Manufacturers Enter into Antidepressant Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Antidepressant Drugs Sales by Product (2014-2019) (MT)
Table Global Antidepressant Drugs Sales Share by Product (2014-2019)
Figure Global Antidepressant Drugs Sales Market Share by Product (2014-2019)
Figure Global Antidepressant Drugs Sales Market Share by Product in 2018
Table Global Antidepressant Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Antidepressant Drugs Revenue Share by Product (2014-2019)
Figure Global Antidepressant Drugs Revenue Market Share by Product (2014-2019)
Figure Global Antidepressant Drugs Revenue Market Share by Product in 2018
Table Antidepressant Drugs Price by Product 2014-2019 (USD/Kg)
Table Global Antidepressant Drugs Sales by End User (2014-2019) (MT)
Table Global Antidepressant Drugs Sales Share by End User (2014-2019)
Figure Global Sales Antidepressant Drugs Market Share by End User (2014-2019)
Figure Global Sales Antidepressant Drugs Market Share by End User in 2018
Figure North America Antidepressant Drugs Sales Growth Rate 2014-2019 (MT)
Figure North America Antidepressant Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Antidepressant Drugs Sales by Countries (2014-2019) (MT)
Table North America Antidepressant Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Antidepressant Drugs Sales Market Share by Countries
Table North America Antidepressant Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Antidepressant Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Antidepressant Drugs Revenue Market Share by Countries
Figure United States Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure United States Antidepressant Drugs Revenue Growth Rate (2014-2019) (MT)
Figure Canada Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Canada Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Mexico Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Antidepressant Drugs Sales by Product (2014-2019) (MT)
Table North America Antidepressant Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Antidepressant Drugs Market Share by Product
Table North America Antidepressant Drugs Sales by End User (2014-2019) (MT)
Table North America Antidepressant Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Antidepressant Drugs Market Share by End User
Figure Europe Antidepressant Drugs Sales Growth Rate 2014-2019 (MT)
Figure Europe Antidepressant Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Antidepressant Drugs Sales by Countries (2014-2019) (MT)
Table Europe Antidepressant Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Antidepressant Drugs Sales Market Share by Countries
Table Europe Antidepressant Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Antidepressant Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Antidepressant Drugs Revenue Market Share by Countries
Figure Germany Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Germany Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure France Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure UK Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Italy Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Russia Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Antidepressant Drugs Sales by Product (2014-2019) (MT)
Table Europe Antidepressant Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Antidepressant Drugs Market Share by Product
Table Europe Antidepressant Drugs Sales by End User (2014-2019) (MT)
Table Europe Antidepressant Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Antidepressant Drugs Market Share by End User
Figure Asia Pacific Antidepressant Drugs Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Antidepressant Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Antidepressant Drugs Sales by Countries (2014-2019) (MT)
Table Asia Pacific Antidepressant Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antidepressant Drugs Sales Market Share by Countries
Table Asia Pacific Antidepressant Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Antidepressant Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antidepressant Drugs Revenue Market Share by Countries
Figure China Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure China Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Japan Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Korea Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure India Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Australia Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Philippines Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Thailand Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Singapore Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Antidepressant Drugs Sales by Product (2014-2019) (MT)
Table Asia Pacific Antidepressant Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Antidepressant Drugs Market Share by Product
Table Asia Pacific Antidepressant Drugs Sales by End User (2014-2019) (MT)
Table Asia Pacific Antidepressant Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Antidepressant Drugs Market Share by End User
Figure Central & South America Antidepressant Drugs Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Antidepressant Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Antidepressant Drugs Sales by Countries (2014-2019) (MT)
Table Central & South America Antidepressant Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antidepressant Drugs Sales Market Share by Countries
Table Central & South America Antidepressant Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Antidepressant Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antidepressant Drugs Revenue Market Share by Countries
Figure Brazil Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Brazil Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Argentina Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Antidepressant Drugs Sales by Product (2014-2019) (MT)
Table Central & South America Antidepressant Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Antidepressant Drugs Market Share by Product
Table Central & South America Antidepressant Drugs Sales by End User (2014-2019) (MT)
Table Central & South America Antidepressant Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Antidepressant Drugs Market Share by End User
Figure Middle East and Africa Antidepressant Drugs Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Antidepressant Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Antidepressant Drugs Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Antidepressant Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antidepressant Drugs Sales Market Share by Countries
Table Middle East and Africa Antidepressant Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Antidepressant Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antidepressant Drugs Revenue Market Share by Countries
Figure GCC Countries Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Turkey Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure Egypt Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Antidepressant Drugs Sales Growth Rate (2014-2019) (MT)
Figure South Africa Antidepressant Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Antidepressant Drugs Sales by Product (2014-2019) (MT)
Table Middle East and Africa Antidepressant Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Antidepressant Drugs Market Share by Product
Table Middle East and Africa Antidepressant Drugs Sales by End User (2014-2019) (MT)
Table Middle East and Africa Antidepressant Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Antidepressant Drugs Market Share by End User
Table Alkermes Company Details
Table Alkermes Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Alkermes Recent Development
Table Allergan Company Details
Table Allergan Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Allergan Recent Development
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Bristol Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Lundbeck Company Details
Table Lundbeck Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Lundbeck Recent Development
Table Merck Company Details
Table Merck Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Teva Company Details
Table Teva Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Teva Recent Development
Table Takeda Company Details
Table Takeda Antidepressant Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Takeda Recent Development
Table Global Antidepressant Drugs Sales Forecast by Regions 2019-2025 (MT)
Table Global Antidepressant Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Antidepressant Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Antidepressant Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Antidepressant Drugs Sales Forecast by Product 2019-2025 (MT)
Table Global Antidepressant Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Antidepressant Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Antidepressant Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Antidepressant Drugs Sales Forecast by End User 2019-2025 (MT)
Table Global Antidepressant Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Antidepressant Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Antidepressant Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Antidepressant Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Antidepressant Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Antidepressant Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Antidepressant Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Antidepressant Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Antidepressant Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Antidepressant Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Antidepressant Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Antidepressant Drugs Value Chain
Table Antidepressant Drugs Customers List
Table Antidepressant Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
双極性障害の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity le…- 双極性障害治療法の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. In 2018, the global Bipolar Disorder Therapeu…
- 大うつ病性障害（MDD）の世界市場：市場規模・現状・予測 Major Depressive Disorder (MDD) is a common mental illness characterized by persistent low mood that interferes with the person's ability to eat, work, sleep and other activities. MDD is also referred to as clinical depression or recurrent depression. The common symptoms of this mental disorder are …
- 世界の季節性情動障害治療薬市場：専門的調査 Seasonal affective disorder or SAD is a recurrent major depressive disorder with a seasonal pattern usually beginning in fall and continuing into winter months. The global Seasonal Affective Disorder Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, …
- 抗うつ薬の世界市場：インサイト・予測 Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperact…